Zhejiang Xianju Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Zhejiang Xianju Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Zhejiang Xianju Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Selling expenses266,862,6820.04512612015-06-30historic
Other current liabilities209,376,4380.0354872015-06-30historic
Non-operating loss4,640,4337.8E-41062015-06-30historic
Investment income from associate and joint venture7,259,1120.001231362015-06-30historic
Construction materials1,829,8103.1E-41592015-06-30historic
Notes receivable191,524,3510.032381852015-06-30historic
Long term equity investment154,603,1320.026142462015-06-30historic
Cash paid for taxes111,922,2320.018922692015-06-30historic
Short term borrowings758,000,2070.128152972015-06-30historic
Cash from other investing activities5,002,6658.5E-43022015-06-30historic
Financial expenses31,899,6830.005393202015-06-30historic
Cash paid for dividends, profits or interests79,962,0970.013523382015-06-30historic
Cash inflows from operating activities1,387,901,6110.234653692015-06-30historic
Total cost of goods sold1,140,626,5500.192843742015-06-30historic
Cash outflows from operating activities1,337,920,2000.22623772015-06-30historic
Fixed assets965,839,8720.163293842015-06-30historic
Revenue1,181,301,1460.199723862015-06-30historic
Comprehensive income attributable to minority shareholders1,360,6872.3E-44182015-06-30historic
Minority interests gain1,360,6872.3E-44222015-06-30historic
Long term borrowings119,300,0000.020174282015-06-30historic
Other receivables45,620,4990.007714462015-06-30historic
Interests payable2,385,2224.0E-44472015-06-30historic
Diluted eps00.04782015-06-30historic
Refunds of taxes3,087,6625.2E-44802015-06-30historic
Cash inflows from financing activities545,839,2980.092285082015-06-30historic
Total liabilities1,603,227,0720.271065192015-06-30historic
Other payables71,037,0020.012015342015-06-30historic
Total non-current assets1,374,482,3330.232385442015-06-30historic
Inventories383,023,5060.064765592015-06-30historic
Accounts payable246,140,2640.041615672015-06-30historic
Payroll payable15,481,2240.002625782015-06-30historic
Deferred tax assets14,537,6820.002465932015-06-30historic
Intangible assets94,792,1590.016036382015-06-30historic
Disposal of fixed assets and others60,6551.0E-56392015-06-30historic
Purchases of fixed assets and others40,396,4530.006836422015-06-30historic
Total liabilities and equity2,823,673,6610.477396662015-06-30historic
Operating profit47,933,7080.00816712015-06-30historic
Net income43,754,4620.00746972015-06-30historic
Total comprehensive income43,712,6980.007397022015-06-30historic
Net cash flows from investing activities-65,033,133-0.0117172015-06-30historic
Prepayment38,251,4740.006477192015-06-30historic
Total profit48,248,7520.008167302015-06-30historic
Minority interest15,628,4630.002647732015-06-30historic
Capital reserve411,551,0400.069588132015-06-30historic
Net cash and cash equivalents ending balance219,446,6150.03718572015-06-30historic
Net change in cash-84,405,253-0.014279982015-06-30historic
Net cashflow from financing activities-72,072,800-0.0121910672015-06-30historic
Other current assets155,9883.0E-510852015-06-30historic